Misfolded tau aggregates from brains of individuals with AD or tauopathies [6, 14, 30, 36] or from tau transgenic mouse brains [37] or generated in vitro [18, 27, 32, 50] are able to seed tau aggregation in cultured cells and in vivo. The gene discussed is MAPT; the disease is Alzheimer disease.